71 results
8-K
EX-10.1
GRI
GRI Bio Inc
20 May 24
Entry into a Material Definitive Agreement
4:13pm
10-K
2023 FY
EX-10.26
GRI
GRI Bio Inc
Annual report
28 Mar 24
4:08pm
8-K
EX-10.1
GRI
GRI Bio Inc
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm
8-K
EX-10.3
GRI
GRI Bio Inc
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm
8-K
EX-10.2
GRI
GRI Bio Inc
2 Feb 24
GRI Bio Announces Pricing of $5.5 Million Public Offering
4:23pm
8-K
EX-10.1
b8o v1tcsrz5b
23 Aug 23
GRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIR
9:07am
8-K
EX-10.5
78wzgib8hohhp2 2imw
21 Apr 23
Investment proceeds expected to fund planned operations of the combined company into mid-2024
5:14pm
8-K
EX-10.1
5bmggy wxs2z6
21 Apr 23
Investment proceeds expected to fund planned operations of the combined company into mid-2024
5:14pm
8-K
EX-10.8
vb5on4yf 0ofcsiu3
21 Apr 23
Investment proceeds expected to fund planned operations of the combined company into mid-2024
5:14pm
8-K
EX-10.9
e37rncy
21 Apr 23
Investment proceeds expected to fund planned operations of the combined company into mid-2024
5:14pm
S-4
EX-10.31
6qh2t
23 Dec 22
Registration of securities issued in business combination transactions
6:06am